小鼠MLL-ENL驱动白血病启动效率随年龄变化并在新生儿期达峰
该研究利用转基因小鼠在胎儿、新生儿、幼年和成年阶段诱导MLL-ENL融合基因,发现胎儿或新生儿期诱导时几乎所有小鼠死于AML,而成年期诱导时多数小鼠存活超过1年,且新生儿期短暂抑制MLL-ENL可预防多数小鼠发生AML。MLL-ENL靶基因在新生儿祖细胞中诱导效率高于成年祖细胞,Lin28b抑制而非加速AML启动,这解释了人类婴儿白血病中MLL重排常发生于出生前但转化多发生于出生后的现象。
要点
- MLL-ENL在新生儿期诱导时AML启动效率最高,胎儿期次之,成年期最低。
- 新生儿期短暂抑制MLL-ENL可预防多数小鼠发生AML。
- Lin28b抑制而非加速MLL-ENL驱动的AML启动。
核心结论
- MLL-ENL驱动AML的启动效率随出生前和出生后发育进程而变化,新生儿期最高。
- 发育程序可被调控以阻碍转化,Lin28b抑制AML启动。
研究设计与样本
- 使用转基因小鼠在胎儿、新生儿、幼年和成年阶段诱导MLL-ENL。
- 观察AML发生及MLL-ENL靶基因诱导效率。
主要发现
- 胎儿或新生儿期诱导MLL-ENL时,几乎所有小鼠死于AML。
- 成年期诱导MLL-ENL时,多数小鼠存活超过1年,尽管转基因组持续表达。
- 新生儿期短暂抑制MLL-ENL可预防多数小鼠发生AML。
- MLL-ENL靶基因在新生儿祖细胞中诱导效率高于成年祖细胞。
- 移植应激减轻了白血病发生的发育障碍,Lin28b抑制而非加速AML启动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
MLL rearrangements are translocation mutations that cause both acute lymphoblastic leukemia and acute myeloid leukemia (AML). These translocations can occur as sole clonal driver mutations in infant leukemias, suggesting that fetal or neonatal hematopoietic progenitors may be exquisitely sensitive to transformation by MLL fusion proteins. To test this possibility, we used transgenic mice to induce one translocation product, MLL-ENL, during fetal, neonatal, juvenile and adult stages of life. When MLL-ENL was induced in fetal or neonatal mice, almost all died of AML. In contrast, when MLL-ENL was induced in adult mice, most survived for >1 year despite sustained transgene expression. AML initiation was most efficient when MLL-ENL was induced in neonates, and even transient suppression of MLL-ENL in neonates could prevent AML in most mice. MLL-ENL target genes were induced more efficiently in neonatal progenitors than in adult progenitors, consistent with the distinct AML initiation efficiencies. Interestingly, transplantation stress mitigated the developmental barrier to leukemogenesis. Since fetal/neonatal progenitors were highly competent to initiate MLL-ENL-driven AML, we tested whether Lin28b, a fetal master regulator, could accelerate leukemogenesis. Surprisingly, Lin28b suppressed AML initiation rather than accelerating it. This may explain why MLL rearrangements often occur before birth in human infant leukemia patients, but transformation usually does not occur until after birth, when Lin28b levels decline. Our findings show that the efficiency of MLL-ENL-driven AML initiation changes through the course of pre- and postnatal development, and developmental programs can be manipulated to impede transformation.
引用
- Okeyo-Owuor T, Li Y, Patel RM, et al. The efficiency of murine MLL-ENL-driven leukemia initiation changes with age and peaks during neonatal development. Blood Adv. 2019. PMID: 31405949. doi:10.1182/bloodadvances.2019000554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。